Publications
41
Citations
1,268
Est. group size
~6
Recurring co-author estimate
Active years
8
Publishing since 2018
Typically publishes in teams of ~6 · 25% small-team papers (≤3 authors) · across 7 venues
- Beyond QALYs and Cents: Valuing Health Equity in Cost-Effectiveness Analysis
Deep Blue (University of Michigan) · 2025
- Eliciting Trade-Offs Between Equity and Efficiency: A Methodological Scoping Review
Value in Health · 2023
- Simulation modeling of breast cancer endocrine therapy duration by patient and tumor characteristics
Cancer Medicine · 2021
- Simulation of Chemotherapy Effects in Older Breast Cancer Patients With High Recurrence Scores
JNCI Journal of the National Cancer Institute · 2019
- Epidemiological Determinants of Advanced Prostate Cancer in Elderly Men in the United States
Clinical Medicine Insights Oncology · 2019
- An ecological approach to monitor geographic disparities in cancer outcomes
PLoS ONE · 2019
- Simulation modeling of the effects of adjuvant chemotherapy in early-stage breast cancer.
Journal of Clinical Oncology · 2019
- Using tumor genomic profile testing and comorbidity level to personalize chemotherapy decisions among older patients with early-stage breast cancer.
Journal of Clinical Oncology · 2019
- Nicotine & Tobacco Research×4
- BMC Public Health×3
- Tobacco Control×3
- International Journal of Environmental Research and Public Health×3
- Value in Health×3
- Yoo Jin Cho
Medicine · The Ohio State University
- Rafael Meza
Medicine · University of Michigan
- David T. Levy
Medicine · University of Michigan
- Luis Zavala‐Arciniega
Medicine · University of Michigan
- Kenneth E. Warner
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile